EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective

Adrianna Witczyńska, Łukasz Fijałkowski iD, Dagmara Mirowska-Guzel iD, Kamila Blecharz-Klin, Alicja Nowaczyk iD

International Journal of Molecular Sciences · 16.10.2025 · 26 (20) · 10080

DOI: 10.3390/ijms262010080 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.10.2025. Verfasst von Adrianna Witczyńska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland. Hauptthemen laut MEDLINE: Propranolol, Adrenergic beta-Antagonists, Receptors, Adrenergic, beta-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Propranolol is a non-selective β-adrenergic receptor antagonist widely used in cardiovascular and neurological therapy. Its naphthalene-based structure contributes to its high lipophilicityand central nervous system penetration. Clinically, propranolol is indicated for hypertension, arrhythmias, anxiety, migraine, and other conditions. It undergoes extensive hepatic metabolism via cytochrome P450 enzymes, notably CYP2D6, with a significant first-pass effect limiting oral bioavailability. This review integrates pharmacological profiling with crystallographic analysis to explore propranolol’s molecular interactions and therapeutic versatility. High-resolution crystal structures of the human β2-adrenergic receptor (hβ2-AR), particularly PDB ID: 6PS5 obtained via serial femtosecond crystallography (SFX), reveal key binding determinants responsible for receptor affinity and antagonism. Comparative structural analysis with other β-blockers—alprenolol, timolol, and carvedilol—highlights how variations in aromatic and heterocyclic frameworks influence pharmacokinetics and receptor selectivity. Superimposition results (RMSD: 0.032 for propranolol–alprenolol, 0.078 for propranolol–carvedilol, and 1.078 for propranolol–timolol) quantitatively illustrate molecular similarity and divergence. The enantioselective behavior of propranolol is also discussed, with the S-enantiomer showing greater receptor affinity and pharmacological potency than the R-form. Beyond canonical β-adrenergic targets, propranolol interacts with non-canonical proteins such as the cellulase enzyme Cel7A and lactoferrin, suggesting off-target effects and novel therapeutic potential. These findings underscore the importance of propranolol’s amphiphilic character, stereochemistry, and electrostatic properties in shaping its pharmacological profile. Overall, the integration of crystallographic data with pharmacological insights supports the rational design of next-generation β-adrenergic ligands with enhanced selectivity, bioavailability, and clinical efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololAdrenergic beta-AntagonistsReceptors, Adrenergic, beta-2HumansCrystallography, X-RayAnimals

Stichwörter der Autor:innen

Cel7A enzymehuman β2-adrenergic receptorlactoferrinpropranolol

Substanzen

PropranololAdrenergic beta-AntagonistsReceptors, Adrenergic, beta-2

Autor:innen und Institutionen

  • Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 87-100 Toruń, Poland.
  • Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology CePT, Medical University of Warsaw, Centre for Preclinical Research and Technology, Banacha 1b, 02-097 Warsaw, Poland.

ORCID-Profile: Łukasz Fijałkowski, Dagmara Mirowska-Guzel, Alicja Nowaczyk

Zitieren

APA

Witczyńska, A., Fijałkowski, Ł., Mirowska-Guzel, D., Blecharz-Klin, K., & Nowaczyk, A. (2025). Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective. International Journal of Molecular Sciences, 26(20), 10080. https://doi.org/10.3390/ijms262010080

Vancouver

Witczyńska A, Fijałkowski Ł, Mirowska-Guzel D, Blecharz-Klin K, Nowaczyk A. Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective. International Journal of Molecular Sciences. 2025;26(20):10080. doi:10.3390/ijms262010080

BibTeX
@article{Witczyska2025,
  author = {Witczyńska, Adrianna and Fijałkowski, Łukasz and Mirowska-Guzel, Dagmara and Blecharz-Klin, Kamila and Nowaczyk, Alicja},
  title = {Structural and Pharmacological Insights into Propranolol: An Integrated Crystallographic Perspective},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10080},
  doi = {10.3390/ijms262010080}
}
Kostenlos starten →